Target population: Patients enrolled in phase I or II anticancer drug trials. All potential study participants will be s clinical trials

User experience study of digital tools to collect data on wellbeing and side effects in cancer patients

This study looks at new digital tools for cancer patients in early-stage drug trials. It aims to make it easier for patients to report how they feel and any side effects using apps on their phones. This helps doctors understand how treatments affect everyday life.